Skip to content

Lakeshore Examination of Activity and Disability Exercise Response Study

Dose-Response Effects of Transformative Exercise in Improving Health and Function in Adults With Spinal Cord Injury and Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02533882
Acronym
LEADERS
Enrollment
180
Registered
2015-08-27
Start date
2014-12-31
Completion date
2019-08-30
Last updated
2019-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis, Stroke

Brief summary

This study will examine the effectiveness of two types of group exercise classes on the health and functional status in inactive adults age 18-65 with neurological conditions including Multiple Sclerosis, stroke, and spinal cord injury (SCI). Participants will be randomly assigned to one of three groups; Movement to Music, Adapted Yoga, or a waitlist group who will complete a home-based exercise intervention of either Movement to Music or Adapted Yoga.

Interventions

BEHAVIORALAdapted Yoga

Sponsors

Lakeshore Foundation
CollaboratorOTHER
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with stroke * MS - mild to moderate disability (Patient Determined Disease Steps Score 0-6) * Able to use arms or arms/legs for exercise * Ambulatory or use manual wheelchair

Exclusion criteria

* Cognitive impairment (Mini-Mental State Exam score \< 24) * Recent weight change (+/- 25 pounds in 1 year) * Poorly controlled blood pressure * Cardiovascular disease event within the past six months * Severe pulmonary disease * Renal failure * Current tobacco user or quit within the last six months * Current use of medications for psychosis * Active pressure ulcers

Design outcomes

Primary

MeasureTime frameDescription
Cardiorespiratory Fitness as measured by sub-maximal VO212 weeksSubmax VO2 is assessed by the six minute walk test or the six minute push test. Participants wear a portable metabolic cart while walking or pushing
Pain as measured by PROMIS Pain Interference Short Form 8a12 weeks
Fatigue as measured by PROMIS Fatigue Short Form 8a12 weeks
Loneliness as measured by the Three-Item Loneliness Scale12 weeks
Grip Strength as measured by hand grip dynamometer12 weeks
Strength as measured by Biodex System 3 Multijoint dynamometer12 weeksUpper body strength is measured using a closed chain push/pull protocol. Lower body strength is measured using the knee flexion/extension protocol.
Balance as measured by the Timed Up and Go12 weeksThe Timed to Up and Go test is performed using a chair with arms. The participants stand up from the chair, walk to a mark measured three meters from the chair then return back to the seat. A score of greater than or equal to 14 seconds (average) has been shown to indicate a high risk of falling.
Balance as measured by Biodex Limits of Stability12 weeksThe Limits of Stability test is performed on the Biodex SD balance machine using the limits of stability protocol created by Biodex.
Balance as measured by Repeated Chair Stands12 weeksThe repeated chair stands test is performed by asking participants to stand up and sit down 5 times as fast as possible. A score of greater than or equal to 14 seconds (average) has been shown to indicate a high risk of falling.

Secondary

MeasureTime frame
Sleep Disturbance as measured by PROMIS Sleep Disturbance Short Form 8a12 weeks
Ability to participate in social roles and activities as measured by PROMIS Ability to Participate in Social Roles and Activities Short Form 8a12 weeks
Health Biomarkers as measured by blood analysis (insulin)12 weeks
Physical Exercise Self-Efficacy as measured by the Physical Exercise Self Efficacy Scale12 weeks
PROMIS Pain Intensity Short Form12 Weeks
Nutrition Self-Efficacy as measured by the Nutrition Self-Efficacy Scale12 weeks
Health Biomarkers as measured by blood analysis (lipids)12 weeks
Health Biomarkers as measured by blood analysis (fasting glucose)12 weeks
Blood pressure12 weeks
Anthropometric measurements (weight)12 weeks
Circumference measurements to be reported as composite ratios (waist circumference, hip circumference, neck circumference)12 weeks
Physical Function with Mobility Aid as measured by PROMIS Physical Function with Mobility Aid 455b12 weeks
Anxiety as measured by PROMIS Emotional Distress-Anxiety Short Form 8a12 weeks
Depression as measured by PROMIS Emotional Distress-Depression Short Form 8a12 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026